Baker Bros. Advisors LP
- SEC CIK
- 0001263508
- 最新申報
- 2026/8/14
2021 年第 3 季持倉
持倉截至 2021/9/30，2021/11/15 申報。只含多頭部位，變化是跟 2021 年第 2 季比股數。
- 持股檔數
- 122
- 較 2021 年第 2 季 +2
- 總值
- $227.7 億
- 較 2021 年第 2 季 +$173.6 萬 (0.0%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| SGENSeagen Inc. | COM | 47,288,259 | $80.3 億 | 35.3% | 00.0% | 不變 | 歷史 |
| ONCBeOne Medicines Ltd. | ADR | 11,668,897 | $42.4 億 | 18.6% | 00.0% | 不變 | 歷史 |
| INCYIncyte Corp | COM | 32,022,125 | $22.0 億 | 9.7% | +3930.0% | 加碼 | 歷史 |
| KODKodiak Sciences Inc. | COM | 14,681,304 | $14.1 億 | 6.2% | +543,423+3.8% | 加碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 4,541,604 | $7.24 億 | 3.2% | +1,001,334+28.3% | 加碼 | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 41,910,704 | $6.96 億 | 3.1% | 00.0% | 不變 | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 7,620,494 | $5.89 億 | 2.6% | +31,200+0.4% | 加碼 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 1,119,557 | $3.38 億 | 1.5% | 00.0% | 不變 | 歷史 |
| PRLDPrelude Therapeutics Inc | COM | 10,123,824 | $3.16 億 | 1.4% | 00.0% | 不變 | 歷史 |
| NVTAInvitae Corp | COM | 9,873,488 | $2.81 億 | 1.2% | −375,087−3.7% | 減碼 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 1,409,784 | $2.49 億 | 1.1% | 00.0% | 不變 | 歷史 |
| ABCLAbCellera Biologics Inc. | COM | 10,450,180 | $2.09 億 | 0.9% | 00.0% | 不變 | 歷史 |
| IGMSIGM Biosciences, Inc. | COM | 3,156,102 | $2.08 億 | 0.9% | 00.0% | 不變 | 歷史 |
| BCRXBiocryst Pharmaceuticals Inc | COM | 12,710,818 | $1.83 億 | 0.8% | 00.0% | 不變 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 2,384,742 | $1.40 億 | 0.6% | +425,531+21.7% | 加碼 | 歷史 |
| PACBPacific Biosciences of California, Inc. | COM | 5,444,963 | $1.39 億 | 0.6% | +2,242,991+70.1% | 加碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 1,499,213 | $1.20 億 | 0.5% | 00.0% | 不變 | 歷史 |
| LEGNLegend Biotech Corp | SPONSORED ADS | 2,364,003 | $1.20 億 | 0.5% | +699,469+42.0% | 加碼 | 歷史 |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 21,856,032 | $1.11 億 | 0.5% | −4,597,390−17.4% | 減碼 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 2,520,730 | $9,344 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| HRTXHeron Therapeutics, Inc. | COM | 8,131,678 | $8,693 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| CERSCerus Corp | COM | 13,713,195 | $8,351 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| GBTGlobal Blood Therapeutics, Inc. | COM | 3,217,441 | $8,198 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| ALLKAllakos Inc. | COM | 703,050 | $7,443 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 2,454,082 | $7,352 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 14,614,264 | $7,161 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| TILInstil Bio, Inc. | COM | 3,893,700 | $6,960 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| VERVVerve Therapeutics, Inc. | COM | 1,416,530 | $6,658 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| VSTMVerastem, Inc. | COM | 21,491,630 | $6,619 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 599,110 | $6,563 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 676,975 | $6,493 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 2,156,001 | $5,938 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| IMTXImmatics N.V. | SHS | 4,423,731 | $5,751 萬 | 0.3% | +140,793+3.3% | 加碼 | 歷史 |
| Apellis Pharmaceuticals, Inc.03753UAB2 | NOTE 3.500% 9/1 | – | $5,726 萬 | 0.3% | – | – | – |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 9,830,877 | $5,083 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 3,863,239 | $5,045 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ZYMEZymeworks Inc. | COM | 1,708,472 | $4,961 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 2,039,772 | $4,946 萬 | 0.2% | +1,852,857+991.3% | 加碼 | 歷史 |
| BLUEbluebird bio, Inc. | COM | 2,499,715 | $4,777 萬 | 0.2% | +2,272,727+1,001.3% | 加碼 | 歷史 |
| TLISTalis Biomedical Corp | COM | 7,574,835 | $4,734 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| FMTXForma Therapeutics Holdings, Inc. | SHS | 2,024,876 | $4,696 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| MRUSMerus N.V. | COM | 2,037,469 | $4,482 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| INSMED Inc457669AB5 | NOTE 0.750% 6/0 | – | $4,384 萬 | 0.2% | – | – | – |
| Sarepta Therapeutics, Inc.803607AB6 | DBCV 1.500%11/1 | – | $4,317 萬 | 0.2% | – | – | – |
| RAREUltragenyx Pharmaceutical Inc. | COM | 444,444 | $4,008 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ALKSAlkermes plc. | SHS | 1,228,170 | $3,788 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| FLGTFulgent Genetics, Inc. | COM | 401,016 | $3,607 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| JBIOJade Biosciences, Inc. | COM | 1,652,171 | $3,466 萬 | 0.2% | +223,600+15.7% | 加碼 | 歷史 |
| ALGSAligos Therapeutics, Inc. | COM | 2,076,400 | $3,221 萬 | 0.1% | +466,400+29.0% | 加碼 | 歷史 |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 2,799,577 | $3,189 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 607,735 | $3,173 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Tricida, Inc.89610FAB7 | NOTE 3.500% 5/1 | – | $3,138 萬 | 0.1% | – | – | – |
| NGNENeurogene Inc. | COM | 3,821,740 | $2,763 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM | 3,410,106 | $2,711 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CYVNYOpthea Ltd | SPONSORED ADS | 3,382,797 | $2,706 萬 | 0.1% | −29,265−0.9% | 減碼 | 歷史 |
| BCABBioAtla, Inc. | COM | 825,000 | $2,429 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| KDNYChinook Therapeutics, Inc. | COM | 1,903,069 | $2,428 萬 | 0.1% | +822,676+76.1% | 加碼 | 歷史 |
| NVAXNovavax Inc | COM NEW | 108,756 | $2,255 萬 | 0.1% | −35,000−24.3% | 減碼 | 歷史 |
| RETAReata Pharmaceuticals Inc | CL A | 223,976 | $2,253 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| BCELAtreca, Inc. | CL A COM | 3,532,760 | $2,201 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| DSGNDesign Therapeutics, Inc. | COM | 1,436,636 | $2,110 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 2,591,366 | $2,019 萬 | 0.1% | 00.0% | 不變 | – |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 920,656 | $1,938 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| DICEDICE Therapeutics, Inc. | COM | 588,235 | $1,927 萬 | 0.1% | +588,235 | 新進 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,127,273 | $1,883 萬 | 0.1% | +727,273+181.8% | 加碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 539,057 | $1,777 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| SRZNSurrozen, Inc. | COM | 2,500,000 | $1,770 萬 | 0.1% | +2,500,000 | 新進 | 歷史 |
| OTICOtonomy, Inc. | COM | 7,694,038 | $1,477 萬 | 0.1% | +471,564+6.5% | 加碼 | 歷史 |
| CYTCyteir Therapeutics, Inc. | COM | 812,640 | $1,426 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 647,313 | $1,289 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ALBOAlbireo Pharma, Inc. | COM | 412,466 | $1,287 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Invitae Corp46185LAB9 | NOTE 2.000% 9/0 | – | $1,257 萬 | 0.1% | – | – | – |
| ALTAltimmune, Inc. | COM NEW | 1,072,038 | $1,213 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| TCRXTScan Therapeutics, Inc. | COM | 1,425,000 | $1,189 萬 | 0.1% | +1,425,000 | 新進 | 歷史 |
| ANABAnaptysbio, Inc | COM | 427,179 | $1,159 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| AUPHAurinia Pharmaceuticals Inc. | COM | 520,523 | $1,152 萬 | 0.1% | −599,439−53.5% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 751,639 | $1,149 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 750,000 | $969.8 萬 | <0.1% | +750,000 | 新進 | 歷史 |
| MGNXMacrogenics Inc | COM | 442,579 | $926.8 萬 | <0.1% | +241,900+120.5% | 加碼 | 歷史 |
| KRTXKaruna Therapeutics, Inc. | COM | 69,966 | $855.9 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 500,000 | $830.0 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| CABACabaletta Bio, Inc. | COM | 662,063 | $805.1 萬 | <0.1% | +25,700+4.0% | 加碼 | 歷史 |
| CBAYCymaBay Therapeutics, Inc. | COM | 2,170,464 | $792.2 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| LONALeonaBio, Inc. | COM | 806,367 | $756.4 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Genetron Hldgs Ltd37186H100 | ADS | 455,306 | $630.6 萬 | <0.1% | 00.0% | 不變 | – |
| BMEABiomea Fusion, Inc. | COM | 524,617 | $628.0 萬 | <0.1% | +230,500+78.4% | 加碼 | 歷史 |
| Amryt Pharma PLC03217L106 | SPONSORED ADS | 518,380 | $624.4 萬 | <0.1% | +518,380 | 新進 | – |
| NGMNGM Biopharmaceuticals Inc | COM | 291,801 | $613.4 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 222,222 | $611.3 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| KURAKura Oncology, Inc. | COM | 304,158 | $569.7 萬 | <0.1% | +304,158 | 新進 | 歷史 |
| ATYRaTYR PHARMA INC | COM NEW | 625,000 | $567.5 萬 | <0.1% | +625,000 | 新進 | 歷史 |
| ALECAlector, Inc. | COM | 239,228 | $545.9 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 200,996 | $526.8 萬 | <0.1% | +124,396+162.4% | 加碼 | 歷史 |
| ChemoCentryx, Inc.16383L106 | COM | 301,195 | $515.0 萬 | <0.1% | +301,195 | 新進 | – |
| TCDATricida, Inc. | COM | 1,037,432 | $481.4 萬 | <0.1% | +308,132+42.3% | 加碼 | 歷史 |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 123,600 | $473.8 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Biomarin Pharmaceutical Inc09061GAH4 | NOTE 0.599% 8/0 | – | $461.1 萬 | <0.1% | – | – | – |
| REPLReplimune Group, Inc. | COM | 153,512 | $455.0 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| DNLIDenali Therapeutics Inc. | COM | 88,738 | $447.7 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| NEXINexImmune, Inc. | COM | 294,117 | $445.3 萬 | <0.1% | 00.0% | 不變 | 歷史 |
2021 年第 2 季之後清倉（10 檔）
2021 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 2 季股數 | 2021 年第 2 季市值 | 2021 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| APLSApellis Pharmaceuticals, Inc. | COM | 2,271,917 | $1.44 億 | 0.6% | 歷史 |
| ADCTADC Therapeutics SA | SHS | 1,418,107 | $3,453 萬 | 0.2% | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 455,276 | $2,043 萬 | 0.1% | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 1,406,037 | $887.2 萬 | <0.1% | 歷史 |
| ASMBAssembly Biosciences, Inc. | COM | 2,108,621 | $818.1 萬 | <0.1% | 歷史 |
| SPRYARS Pharmaceuticals, Inc. | COM | 238,095 | $735.5 萬 | <0.1% | 歷史 |
| Chiasma, Inc16706W102 | COM | 1,420,740 | $672.0 萬 | <0.1% | – |
| ORTXOrchard Therapeutics plc | ADS | 1,192,003 | $523.3 萬 | <0.1% | 歷史 |
| KRROKorro Bio, Inc. | COM | 55,555 | $55.3 萬 | <0.1% | 歷史 |
| SYRSSyros Pharmaceuticals, Inc. | COM | 65,497 | $35.7 萬 | <0.1% | 歷史 |